Fate Therapeutics FATE
NASDAQ FATE
$2.07 +0.01 (+0.49%)
At close: Oct 21, 2026 · 4:00 PM EDT

Fate Therapeutics (FATE) Pension (2023)

Updated

Fate Therapeutics (FATE) posted Pension of $12.9 million for Q3 2023, unchanged from the prior quarter.

Analysis

Fate Therapeutics (FATE) Pension (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Fate Therapeutics 248.02 Mn 94.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 12.90 Mn
Jun 30, 2023 12.90 Mn
Mar 31, 2023 12.90 Mn
API Access

Fate Therapeutics Pension API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=pension&ticker=FATE&period=max&api_key=YOUR_API_KEY